Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Crushed vs Whole Bedaquiline Tablets
NCT03032367Phase 1Completed
- Sponsor
- IMPAACT Network
- Start
- Nov 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bedaquiline in Tuberculosis (TB) (2 arms), sponsored by IMPAACT Network. Primary endpoint: Bioequivalence of bedaquiline (PK parameters) at Day 15. Started Nov 2016; status: completed.
02
Drugs
bedaquiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03032367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03032367.